| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8404 |
| Human Intestinal Absorption | HIA+ | 0.8569 |
| Caco-2 Permeability | Caco2+ | 0.5932 |
| P-glycoprotein Substrate | Substrate | 0.5000 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9609 |
| Non-inhibitor | 0.6845 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9558 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7605 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8389 |
| CYP450 2D6 Substrate | Non-substrate | 0.8857 |
| CYP450 3A4 Substrate | Non-substrate | 0.6058 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6240 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8956 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9440 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9369 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8480 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9736 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9634 |
| Non-inhibitor | 0.8786 |
| AMES Toxicity | Non AMES toxic | 0.9570 |
| Carcinogens | Non-carcinogens | 0.7224 |
| Fish Toxicity | High FHMT | 0.9673 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9994 |
| Honey Bee Toxicity | High HBT | 0.6179 |
| Biodegradation | Ready biodegradable | 0.6274 |
| Acute Oral Toxicity | III | 0.7245 |
| Carcinogenicity (Three-class) | Non-required | 0.7733 |